Details SHOW SMILES / InChI SMILES CCCCCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCCCCCC(N)=O InChI InChIKey=XEUVNVNAVKZSPT-JTJYXVOQSA-N InChI=1S/C27H44N4O5/c1-4-6-8-12-24(34)30-22(18-20-13-15-21(32)16-14-20)26(35)31-25(19(3)5-2)27(36)29-17-10-7-9-11-23(28)33/h13-16,19,22,25,32H,4-12,17-18H2,1-3H3,(H2,28,33)(H,29,36)(H,30,34)(H,31,35)/t19-,22-,25-/m0/s1 Approval Year ACTIVE MOIETY PRODRUG (METABOLITE ACTIVE)
In the words of our Co-founder & CEO, Christopher Savoie: "We're proud to support the brave men and women of USSOCOM in defending our national security around the world
This is where BPC-157 shines for bodybuilders: Joint and Tendon Repair Post-Cycle After cycling off compounds like Testosterone , Trenbolone , or Winstrol , many athletes use BPC-157 to mitigate stress on tendons and joints, allowing for faster tissue repair without relying on NSAIDs or corticosteroids
Gallbladder disease In patients with established gallbladder disease, the relative risks and benefits of a cholecystectomy or preventive treatment with ursodeoxycholic acid before starting GLP-1 receptor agonist therapy should be thoroughly discussed
